CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer [Phase 2]
Summary
Phase 2 trial of Avelumab in recurrent or metastatic nasopharyngeal cancer was terminated, with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assuntina Sacco, M.D. | Conditions: Nasopharyngeal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2019-09-06